Vimarsana
Biggest News Aggregation in the World

Page 2 - Presentation Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presentation Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presentation Session Today - Breaking & Trending Today

New clinical and real-world data for Roche's Vabysmo at ASRS reveal improved outcomes for people with two leading causes of vision loss - Vimarsana News

New clinical and real-world data for Roche's Vabysmo at ASRS reveal improved outcomes for people with two leading causes of vision loss

Late-breaking post-hoc data indicate Vabysmo leads to less fibrosis, which may negatively impact vision, than aflibercept in people with diabetic macular edema Real-world data reinforce that...

New Clinical and Real-World Data for Genentech's Vabysmo at ASRS Reveal Improved Outcomes for People With Two Leading Causes of Vision Loss - Vimarsana News

New Clinical and Real-World Data for Genentech's Vabysmo at ASRS Reveal Improved Outcomes for People With Two Leading Causes of Vision Loss

‒ Late-breaking post-hoc data indicate Vabysmo leads to less fibrosis, which may negatively impact vision, than aflibercept in people with diabetic macular edema (DME) –‒ Real-world data reinforce that first-line Vabysmo use improves outcomes and extends treatment intervals rapidly during the first four months for p...

Onera Health: Onera Launches Medical Advisory Board to Support Company Growth - Vimarsana News

Onera Health: Onera Launches Medical Advisory Board to Support Company Growth

Onera Health has announced the formation of a Medical Advisory Board ahead of SLEEP 2023, the Associated Professional Sleep Societies, LLC (APSS) annual meeting, where the company exhibits and presents

Onera Establishes Medical Advisory Board - Vimarsana News

Onera Establishes Medical Advisory Board

Onera Health, developer of a patch-based home sleep test, established a medical advisory board to support company growth.

Promontory Therapeutics to Present Research on PT-112 in Prostate Cancer at the 34th EORTC-NCI-AACR Symposium - Vimarsana News

Promontory Therapeutics to Present Research on PT-112 in Prostate Cancer at the 34th EORTC-NCI-AACR Symposium

/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, today announced...